Page last updated: 2024-08-26

oxoglaucine and yttrium

oxoglaucine has been researched along with yttrium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, ZF; Jiang, YH; Khan, TM; Li, ZQ; Liang, H; Liu, YC; Qin, JL; Shen, WY; Wang, M; Wei, JH	1

Other Studies

1 other study(ies) available for oxoglaucine and yttrium

Article	Year
Water-soluble oxoglaucine-Y(III), Dy(III) complexes: in vitro and in vivo anticancer activities by triggering DNA damage, leading to S phase arrest and apoptosis. Dalton transactions (Cambridge, England : 2003), 2015, Jul-07, Volume: 44, Issue:25 Topics: Animals; Antineoplastic Agents; Apomorphine; Apoptosis; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Survival; Coordination Complexes; DNA; DNA Damage; Dysprosium; Humans; Medicine, Chinese Traditional; Mice; Neoplasms; Proto-Oncogene Proteins c-bcl-2; S Phase; Solubility; Topoisomerase Inhibitors; Tumor Burden; Water; X-Ray Diffraction; Yttrium	2015

Article

Year

Water-soluble oxoglaucine-Y(III), Dy(III) complexes: in vitro and in vivo anticancer activities by triggering DNA damage, leading to S phase arrest and apoptosis.

Dalton transactions (Cambridge, England : 2003), 2015, Jul-07, Volume: 44, Issue:25

Topics: Animals; Antineoplastic Agents; Apomorphine; Apoptosis; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Survival; Coordination Complexes; DNA; DNA Damage; Dysprosium; Humans; Medicine, Chinese Traditional; Mice; Neoplasms; Proto-Oncogene Proteins c-bcl-2; S Phase; Solubility; Topoisomerase Inhibitors; Tumor Burden; Water; X-Ray Diffraction; Yttrium

2015